Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician in the frame of a PASS study and described the occurrence of ileocolic intussusception in a 6-month-old male subject who was vaccinated with ROTARIX, GlaxoSmithKline. The subject was on no other medications and had no relevant medical history and no allergy. Previous vaccination included ROTARIX (GlaxoSmithKline, oral) given on 13 February 2008. On 14 April 2008, the subject received 2nd dose of ROTARIX (oral). Lot number not provided. On 4 May 2008, 20 days after vaccination with ROTARIX, the subject started with irritability, colic pain, vomiting (5) and fever. The subject was hospitalized on 4 May 2008 with hyperemic pharynx and without evidence of abdominal complication. Later, the patient experienced tympanic abdomen, persistent pain, abdominal distension and bloody stools. Surgery was done on 5 May 2008. Invagination ileo-ileo-colic with intestinal necrosis was found and corrected by taxis. Intestinal resection of necrosed segment and term to term anastomosis at 4 cm of ileocaecal valve was performed. Necrotic segment was 20 cm. Post surgical evolution showed cough and surgical site infection with good response to antibiotics treatment, without more complication. Laboratory tests performed on 5 May 2008 showed the following: Hemoglobin: 11.2 g/dl, hematocrit: 32.1%, leukocytes: 15500/mm3, neutrophils: 10500/mm3, lymphocytes: 4000/mm3, bands: 2%, platelets: 458000/mm3. The subject was treated with paracetamol, metronidazole and amikacin. Clinical recuperation was favorable, the subject evolved in good clinical conditions. The date of discharge was not available in the chart. At the time of reporting the events were resolved. The physician considered the events were possibly related to vaccination with ROTARIX.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166